Literature DB >> 8832229

Mifepristone prevents the expression of long-term behavioural sensitization to amphetamine.

T J De Vries1, A N Schoffelmeer, G H Tjon, P Nestby, A H Mulder, L J Vanderschuren.   

Abstract

Three weeks following intermittent amphetamine exposure (2.5 mg/kg/day for 5 days), rats showed an enhanced locomotor response to an amphetamine challenge. Mifepristone (20 mg/kg) given 45 min prior to the challenge completely prevented the expression of amphetamine hyperresponsiveness. The glucocorticoid antagonist did not affect the locomotor response to amphetamine in drug-naive rats. These data demonstrate for the first time that glucocorticoid receptor antagonist treatment may prevent long-term hyperreactivity to drugs of abuse in individuals with a drug history.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832229     DOI: 10.1016/0014-2999(96)00308-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors.

Authors:  M Schwendt; J F McGinty
Journal:  Neuroscience       Date:  2010-03-15       Impact factor: 3.590

2.  Environmental-induced differences in corticosterone and glucocorticoid receptor blockade of amphetamine self-administration in rats.

Authors:  Dustin J Stairs; Mark A Prendergast; Michael T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2011-09-02       Impact factor: 4.530

3.  Corticosterone administration up-regulated expression of norepinephrine transporter and dopamine β-hydroxylase in rat locus coeruleus and its terminal regions.

Authors:  Yan Fan; Ping Chen; Ying Li; Kui Cui; Daniel M Noel; Elizabeth D Cummins; Daniel J Peterson; Russell W Brown; Meng-Yang Zhu
Journal:  J Neurochem       Date:  2013-10-10       Impact factor: 5.372

4.  A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats.

Authors:  L J Vanderschuren; E D Schmidt; T J De Vries; C A Van Moorsel; F J Tilders; A N Schoffelmeer
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

5.  Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine.

Authors:  W J Giardino; R Pastor; A M J Anacker; E Spangler; D M Cote; J Li; M P Stenzel-Poore; T J Phillips; A E Ryabinin
Journal:  Genes Brain Behav       Date:  2010-09-30       Impact factor: 3.449

6.  Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking.

Authors:  Jeffrey A Simms; Carolina L Haass-Koffler; Jade Bito-Onon; Rui Li; Selena E Bartlett
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

7.  Mifepristone treatment affects the response to repeated amphetamine injections, but does not attenuate the expression of sensitization.

Authors:  Rixt van der Veen; Marieke C S Boshuizen; E Ronald de Kloet
Journal:  Psychopharmacology (Berl)       Date:  2013-12       Impact factor: 4.530

8.  Morphine-induced increase in D-1 receptor regulated signal transduction in rat striatal neurons and its facilitation by glucocorticoid receptor activation: possible role in behavioral sensitization.

Authors:  A N Schoffelmeer; P Voorn; A J Jonker; G Wardeh; P Nestby; L J Vanderschuren; T J De Vries; A H Mulder; G H Tjon
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

9.  The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat.

Authors:  Uri Shalev; Michela Marinelli; Michael H Baumann; Pier-Vincenzo Piazza; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2002-09-18       Impact factor: 4.530

10.  Stress enables synaptic depression in CA1 synapses by acute and chronic morphine: possible mechanisms for corticosterone on opiate addiction.

Authors:  Ya Yang; Xigeng Zheng; Yongfu Wang; Jun Cao; Zhifang Dong; Jingxia Cai; Nan Sui; Lin Xu
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.